- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Helus Pharma Inc (HELP)
Helus Pharma Inc stock price live, this page displays NLB HELP stock exchange data. View the HELP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Helus Pharma Inc real time stock price chart below.
What Is the Helus Pharma Inc Stock Price Today?
The Helus Pharma Inc stock price today is 16.65.
What Is the Stock Symbol for Helus Pharma Inc?
The stock symbol for Helus Pharma Inc is "HELP."
What Stock Exchange Does Helus Pharma Inc Trade On?
Helus Pharma Inc is listed and trades on the CBOE Canada stock exchange.
Is Helus Pharma Inc a Good Stock to Buy?
Determining whether Helus Pharma Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HELP quote. (ISIN: CA4234921076)
What Is the Helus Pharma Inc Stock Price Today?
The Helus Pharma Inc stock price today is 16.65.
What Is the Stock Symbol for Helus Pharma Inc?
The stock symbol for Helus Pharma Inc is "HELP."
What Stock Exchange Does Helus Pharma Inc Trade On?
Helus Pharma Inc is listed and trades on the CBOE Canada stock exchange.
Is Helus Pharma Inc a Good Stock to Buy?
Determining whether Helus Pharma Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HELP quote. (ISIN: CA4234921076)
Currency in CAD
16.65
-0.30(-1.77%)
Closed·
Fair Value
An estimate of a Helus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.40
17.63
52 wk Range
5.30
20.88
HELP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Helus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.4017.63
52 wk Range
5.3020.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HELP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Helus Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Cybin Inc. completes name change to Helus Pharma- Investing.com
- Cybin Inc. completes name change to Helus Pharma
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Feb 13, 2026
EPS / Forecast
-1.38 / -0.05
Revenue / Forecast
-- / --
Compare HELP to Peers and Sector
Metrics to compare | HELP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHELPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.0x | −2.3x | −0.3x | |
PEG Ratio | −0.42 | −0.05 | 0.00 | |
Price/Book | 3.5x | 1.4x | 2.6x | |
Price / LTM Sales | - | 14.5x | 3.0x | |
Upside (Analyst Target) | - | 87.0% | 58.6% | |
Fair Value Upside | Unlock | 20.4% | 8.4% | Unlock |
Helus Pharma Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company’ preclinical product includes HLP005, a phenethylamine and tryptamine derivative to treat central nervous system. It has a strategic partnership agreement with Segal Trials to evaluating HLP003 for the adjunctive treatment of major depressive disorder; and with Osmind for mental health treatments. The company was formerly known as Cybin Inc. and changed its name to Helus Pharma Inc. in October 2026. The company is headquartered in Toronto, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Helus Pharma (HELP) Stock Price Today?
The Helus Pharma stock price today is 16.65 CAD.
What Stock Exchange Does Helus Pharma Trade On?
Helus Pharma is listed and trades on the CBOE Canada Exchange.
What Is the Stock Symbol for Helus Pharma?
The stock symbol for Helus Pharma is "HELP."
What Is the Helus Pharma Market Cap?
As of today, Helus Pharma market cap is 1.24B CAD.
What Is Helus Pharma's Earnings Per Share (TTM)?
The Helus Pharma EPS (TTM) is -4.05.
From a Technical Analysis Perspective, Is HELP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Helus Pharma Stock Split?
Helus Pharma has split 2 times.
How Many Employees Does Helus Pharma Have?
Helus Pharma has 100 employees.
What is the current trading status of Helus Pharma (HELP)?
As of Oct 03, 2026, Helus Pharma (HELP) is trading at a price of 16.65 CAD, with a previous close of 17.05 CAD. The stock has fluctuated within a day range of 16.40 CAD to 17.63 CAD, while its 52-week range spans from 5.30 CAD to 20.88 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.